Development and validation of HPLC method for vicenin-1 isolated from fenugreek seeds in rat plasma: application to pharmacokinetic, tissue distribution and excretion studies. (1st November 2016)

• Record Type: Journal Article
• Authors: Kandhare, Amit D.; Bodhankar, Subhash L.; Mohan, Vishwaraman; Thakurdesai, Prasad A.
• Is Part Of: Pharmaceutical biology. Volume 54:Number 11(2016:Nov.)
• Page Start: 2575
• Page End: 2583
• Publication Date: 2016-11-01
• Subjects: Bioavailability -- elimination -- flavonoid glycosides -- solid–liquid extraction; Pharmacognosy -- Periodicals; Materia medica, Vegetable -- Periodicals; 615.321
• DOI: 10.3109/13880209.2016.1172245
• Languages: English
• ISSNs: 1388-0209

Abstract

Abstract: Context : Vicenin-1, a flavonol glycoside, has potent platelet aggregation inhibition, antioxidant, radioprotectants and anti-inflammatory activities. Objective : To establish a rapid, simple, precise and sensitive high-performance liquid chromatography (HPLC) method for determination of vicenin-1 in rat plasma, and to investigate the pharmacokinetics, tissue distribution and excretion after a single 60 mg/kg oral dose in rats. Materials and methods : Vicenin-1 was extracted by solid–liquid extraction through Tulsicon ® ADS-400 (0.40–1.2 mm). Chromatographic separation was achieved by HPLC with a C18 column with a mobile phase composed of water and acetonitrile (75:25 v/v) and a flow rate of 1 mL/min along with UV detection at 210 nm. Results : Good linearity of calibration curve was found between 10.5 and 100.5 μg/mL ( R 2 = 0.995) for plasma and tissue, whereas 2.5–500 μg/mL ( R 2 = 0.999) for the urine and stool samples. The extraction recoveries were 98.51–99.58% for vicenin-1 in plasma, whereas intra-day and inter-day precision were validated by relative standard deviation (%RSD), that came in the ranges of 1.16–1.79% and 1.28–1.73%, respectively. The pharmacokinetics results showed C max (7.039 μg/mL) and T max (2 h) after oral administration of vicenin-1. Tissue distribution study showed that the highest concentration of vicenin-1 was achieved in the liver followed by the lung. Approximately 24.2% of its administered dose was excreted via urinary excretion route. Conclusion : The first-pass metabolism, poor solubility and presence of reducing sugar moiety in vicenin-1 may decrease its bioavailability. The developed method is sensitive, specific and was successfully applied to the pharmacokinetics, tissue distribution and excretion studies of vicenin-1 in rats.